Modern Chinese Medicine Group's stock surged 7.08% during intraday trading on Tuesday, following the release of the company's full-year financial results.
The significant price movement appears to be driven by investor reaction to the company's announcement of RMB 145.2 million in full-year revenue, which was disclosed after market hours the previous day.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments